The Staff Investigators at UPCI are excellent physician scientists providing distinctive leadership in the scientific endeavors of UPCI that extends beyond their individual research activities. They are innportant contributors to the interprogramnnatic activities and fulfill the translational objectives ofthe scientific programs. Dr. David Bartlett is a Clinical Staff Investigator providing a significant contribution to the clinical research activities of UPCI. He provides oversight for the multidisciplinary specialty care clinics, tumor boards and provides integration of the clinicla research activities as they relate to each disease site. Dr. Soldano Ferrone is a Research Staff Investigator with extensive experience in cancer biology and immunotherapy. He serves a unique role as a resource for the scientific community at UPCI to design immunixation protocols, screening procedures and characterization strategies of antibodies to clinically relevant molecules. This library of monoclonal antibodies represents a useful source of reagents for the entire UPCI reseach community. Dr. Ferrone is also involved in the research and career development of junior faculty and is responsible for the mentorship program for junior faculty. Dr. IVIichael Lotze has a unique role in UPCI and develops relationships with outside academic institutions, biotechnology and pharaceutical firms of strategic importance forthe UPCI. He is the UPCI representative to the Cancer Biology Training Consortium (CABTRAC) and is a mentor to several UPCI junior faculty. We are requesting support for 1.2 calendar months for each of these three UPCI Staff Investigators who have major programmatic responsibilities.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA047904-25
Application #
8519318
Study Section
Special Emphasis Panel (ZCA1-RTRB-L)
Project Start
Project End
Budget Start
2013-08-01
Budget End
2014-07-31
Support Year
25
Fiscal Year
2013
Total Cost
$102,795
Indirect Cost
$69,737
Name
University of Pittsburgh
Department
Type
DUNS #
004514360
City
Pittsburgh
State
PA
Country
United States
Zip Code
15213
Luu, Thehang; Kim, Kyu-Pyo; Blanchard, Suzette et al. (2018) Phase IB trial of ixabepilone and vorinostat in metastatic breast cancer. Breast Cancer Res Treat 167:469-478
Menk, Ashley V; Scharping, Nicole E; Moreci, Rebecca S et al. (2018) Early TCR Signaling Induces Rapid Aerobic Glycolysis Enabling Distinct Acute T Cell Effector Functions. Cell Rep 22:1509-1521
Redner, Robert L; Beumer, Jan H; Kropf, Patricia et al. (2018) A phase-1 study of dasatinib plus all-trans retinoic acid in acute myeloid leukemia. Leuk Lymphoma 59:2595-2601
Ancevski Hunter, Katerina; Socinski, Mark A; Villaruz, Liza C (2018) PD-L1 Testing in Guiding Patient Selection for PD-1/PD-L1 Inhibitor Therapy in Lung Cancer. Mol Diagn Ther 22:1-10
Frahm, Krystle A; Waldman, Jacob K; Luthra, Soumya et al. (2018) A comparison of the sexually dimorphic dexamethasone transcriptome in mouse cerebral cortical and hypothalamic embryonic neural stem cells. Mol Cell Endocrinol 471:42-50
Pulopulos, Matias M; Vanderhasselt, Marie-Anne; De Raedt, Rudi (2018) Association between changes in heart rate variability during the anticipation of a stressful situation and the stress-induced cortisol response. Psychoneuroendocrinology 94:63-71
Shiffman, Saul; Scholl, Sarah M (2018) Three approaches to quantifying cigarette consumption: Data from nondaily smokers. Psychol Addict Behav 32:249-254
Shayan, Gulidanna; Kansy, Benjamin A; Gibson, Sandra P et al. (2018) Phase Ib Study of Immune Biomarker Modulation with Neoadjuvant Cetuximab and TLR8 Stimulation in Head and Neck Cancer to Overcome Suppressive Myeloid Signals. Clin Cancer Res 24:62-72
Chen, Dongshi; Ni, Hong-Min; Wang, Lei et al. (2018) PUMA induction mediates acetaminophen-induced necrosis and liver injury. Hepatology :
Tahata, Shawn; Singh, Shivendra V; Lin, Yan et al. (2018) Evaluation of Biodistribution of Sulforaphane after Administration of Oral Broccoli Sprout Extract in Melanoma Patients with Multiple Atypical Nevi. Cancer Prev Res (Phila) 11:429-438

Showing the most recent 10 out of 1187 publications